News
Fri Jan 31, 2025
A new therapy combines a drug to mark cancer cells for destruction and a radioactive antibody to kill them, while calculating an extremely safe dose of radiation that uses only the amount of radiation needed to beat the cancer.
Fri Dec 20, 2024
Emily A. Hammad Mrig, PhD, is using natural language processing (NLP) to identify patients and solutions that make molecular diagnostics more affordable and equitable.
Fri Dec 6, 2024
The recognition of Krogan, Shoichet, Manglik, and Giacomini underscores the school’s commitment to fostering groundbreaking research that addresses critical issues in health care and pharmaceutical sciences.
Mon Aug 12, 2024
Department of Pharmaceutical Chemistry faculty member Aashish Manglik, MD, PhD, was celebrated as a curiosity-driven scientist in the 29th annual Byers Award Lecture, where he shared how he fulfilled a research dream in his journey from Stanford University to UCSF.
Wed Jul 31, 2024
David Morris, MD, has worked with many Bay Area startups, including a spin-off from the lab of Department of Pharmaceutical Chemistry faculty member Jim Wells, PhD.
Fri Jul 26, 2024
Department of Pharmaceutical Chemistry faculty members Brian Shoichet, PhD, and Jason Sello, PhD, combine collaboration, curiosity, and innovation to discover molecules that can become anesthetics administered without specialized training.
Wed May 1, 2024
Charles Hart, PhD, director of the Catalyst Program, joins Department of Pharmaceutical Chemistry Chair Michelle Arkin in the center’s ongoing collaboration with academics, government labs, and pharmaceutical companies to develop drug leads that address unmet medical needs.
Tue Apr 16, 2024
Three students with ties to the School were finalists in the event, which challenges graduate students to explain their research to an audience of non-experts in just three minutes.
Mon Mar 18, 2024
School researchers netted $36.7M from 65 grants, fueling efforts spanning drug discovery, bioengineering, pharmacokinetics, clinical pharmacy, and more.
Fri Mar 1, 2024
The GPCR and neuropsychiatric diseases researcher will receive $1.25 million over five years to explore new territory.
- Page 1
- ››